Calithera Biosciences, Inc. Gains 60%
Thu, Sep 05, 2024 at 07:46 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) soared at $0.02, representing a gain of 60%. From Mon, Aug 26, 2024, the stock recorded 60.00% Up Days and 16.67% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 1052%
- Eastside Distilling, Inc. (EAST:NASDAQ), 89.22%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 81.4%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 65.18%
- Inspire Veterinary Partners Inc. (IVP:NASDAQ), 62.95%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- BOQI International Medical Inc. (BIMI:NASDAQ), 50%
- SRM Entertainment Inc. (SRM:NASDAQ), 40.33%
- Tenon Medical Inc. (TNON:NASDAQ), 37.49%
- Ryde Group Ltd. Class A (RYDE:NYSEMKT), 33.85%